Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

Allogeneic Cell Therapies Summit 2021

Evvnt Promotion / evvnt
Archivio
-
17.05.2021 - 19.05.2021  Online
Time: 09:00 - 17:00
 
Temi della conferenza
Patient-specific cell therapies have changed the face of cancer treatment, but with price points sky high and laborious manufacturing processes, this cure is out of reach for many patients.

The 3rd annual Allogeneic Cell Therapies Summit is the only industry-focused meeting dedicated to accelerating the clinical translation of allogeneic cell therapy, to provide an affordable and accessible treatment for patients globally.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Sonny Hsiao, Founder and CEO, Acepodia, Nathan Yee, Associate Director, CMC Product Strategy, Allogeneic Cell Therapy, Bristol Myers Squibb, Joanna Brewer, SVP, Allogeneic Research, Adaptimmune and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/737980-1?pid=4832
Mr. Allogeneic Cell Therapies Team
 
Categorie
Oncologia
Lingua
Inglese
Quote del Congresso
Drug Developers (Earlybird rates and bootcamp day available): USD 2299.0, Academic (Earlybird rates and bootcamp day available): USD 1799.0, Service Providers (Earlybird rates and bootcamp day available): USD 2699.0
I partecipanti attesi
250
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Ärztekammer für WienEuropean Health Forum GasteinÖsterreichische Gesellschaft für Public HealthAGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioCharité International AcademyHilfswerk Austria